Pegvisomant

Details

Files
Generic Name:
Pegvisomant
Project Status:
Complete
Therapeutic Area:
acromegaly
Manufacturer:
Pfizer Canada Inc.
Brand Name:
Somavert
Project Line:
Reimbursement Review
Project Number:
SR0050-000
Submission Type:
Initial
Indications:
acromegaly
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
(tentative)